Breastcancer.org Podcast

338 Episoade

1. Mental Health Benefits of Pets

   Publicat: 19.08.2022
2. How Therapy Can Help People Affected by Breast Cancer

   Publicat: 05.08.2022
3. Fezolinetant: A Non-Hormonal Treatment for Hot Flashes

   Publicat: 22.07.2022
4. Enhertu for HER2-Low Breast Cancer

   Publicat: 08.07.2022
5. Loosening COVID-19 Restrictions and Immunocompromised People: Do You Feel Left Behind?

   Publicat: 24.06.2022
6. Genetic and Genomic Tests: What’s the Difference?

   Publicat: 02.06.2022
7. Just Ask: Increasing Diversity in Clinical Trials

   Publicat: 27.05.2022
8. Dating and Breast Cancer

   Publicat: 29.04.2022
9. Adolescent and Young Adult Breast Cancer

   Publicat: 28.03.2022
10. Top Research Presented at the 2021 San Antonio Breast Cancer Symposium

    Publicat: 21.12.2021
11. Aromatase Inhibitors versus Tamoxifen for Pre-Menopausal Women Diagnosed With Early-Stage, Hormone Receptor-Positive Disease

    Publicat: 13.12.2021
12. Experimental Elacestrant: A Standard of Care for Pre-Treated, Metastatic, Hormone Receptor-Positive, HER2-Negative Breast Cancer?

    Publicat: 11.12.2021
13. Alcohol and Breast Cancer Risk

    Publicat: 05.11.2021
14. Breast Cancer Research at ESMO 2021

    Publicat: 21.10.2021
15. Kisqali Plus Femara Seems Best Option for Advanced-Stage Hormone-Receptor-Positive HER2-Negative Breast Cancer

    Publicat: 01.10.2021
16. Keytruda Added to Chemotherapy Improves Overall Survival for Metastatic PD-L1-Positive, Triple-Negative Breast Cancer

    Publicat: 24.09.2021
17. The Importance of Diversity in Breast Cancer Clinical Trials

    Publicat: 15.09.2021
18. Tattoo Ink Showing Up on Mammograms

    Publicat: 20.08.2021
19. Immunotherapy Keytruda for Early-Stage Triple-Negative Breast Cancer: Better pCR and Lower Recurrence Rates: ESMO 2019 Coverage

    Publicat: 27.07.2021
20. Reconstruction Options After Lumpectomy

    Publicat: 16.07.2021